Antiplatelet therapies: from aspirin to GPIIb/IIIa-receptor antagonists and beyond
- 11 November 1999
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 4 (12) , 552-561
- https://doi.org/10.1016/s1359-6446(99)01394-x
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994
- Aspirin, Heparin, or Both to Treat Acute Unstable AnginaNew England Journal of Medicine, 1988
- Aspirin and Dipyridamole in the Prevention of Re-Stenosis after Percutaneous Transluminal Coronary AngioplastyNew England Journal of Medicine, 1988
- Biochemical evidence of platelet activation in patients with persistent unstable anginaJournal of the American College of Cardiology, 1987
- Platelet Activation in Unstable Coronary DiseaseNew England Journal of Medicine, 1986
- Role of platelets and thrombosis in coronary atherosclerotic disease and sudden deathJournal of the American College of Cardiology, 1985
- Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina.Heart, 1985
- Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable AnginaNew England Journal of Medicine, 1983
- Elevated beta thromboglobulin in peripheral venous blood of patients with acute myocardial ischemia: Direct evidence for enhanced platelet reactivity in vivoThe American Journal of Cardiology, 1981
- Platelet activation in clinical coronary artery disease and spasmAmerican Heart Journal, 1981